Translational Development Acquisition Stock Price, News & Analysis
Company Description
Welcome to the overview page for Translational Development Acquisition (TDAC), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Translational Development Acquisition (TDAC) currently stands at 1.9 thousand shares, down 11.6% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 18.5%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Translational Development Acquisition (TDAC) currently stands at 1.0 days, down 21.3% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 20.8 days.
